DKTK Program
Molecularly Targeted Therapies (MTT)
Activities Partner Site Freiburg
In Freiburg the research program Molecularly Targeted Therapies is contributed to by the Departments of Pediatric Hematology and Oncology as well as the Department of Hematology, Oncology and Stem Cell Transplantation. All Projects belong to the topic Targeting Transcription and Epigenetic. Both departments aim to develop novel therapies to overcome the challenge of fighting successfully different myoproliferative neoplasm to apply novel developments like the detection of circulating tumor DNA/RNA, like targeting II PI3 kinases and JAK kinases as well as improving such technologies like RNAi or CRISPR for the clinical use.
Topic Descriptions will be added the next months.
Dpt. Hematology, Oncology and Stem Cell Transplantation
Dr. Cornelius Miething,
Contributing PD Dr. Ralph Fritsch
Dpt. Pediatric Hematology and Oncology
Prof. Charlotte Niemeyer
Prof. Christian Flotho
Dr. Miriam Erlacher
Dpt. Hematology, Oncology and Stem Cell Transplantation
Prof. Nikolas von Bubnoff
Prof. Justus Duyster
Institute for Surgical Pathology
Prof. Silke Laßmann
Dpt. Hematology, Oncology and Stem Cell Transplantation
Prof. Dr. Justus Duyster
Prof. Dr. Lena Illert
Dpt. Hematology, Oncology and Stem Cell Transplantation
Prof. Justus Duyster
Prof. Robert Zeiser
Prof. Nikolas von Bubnoff
Dpt. Hematology, Oncology and Stem Cell Transplantation
PD Dr. Ralph Fritsch,
contributing Dr. Cornelius Miething